{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:41:50Z","timestamp":1773812510630,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s13577-021-00591-3","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:25:01Z","timestamp":1628533501000},"page":"1653-1661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of platinum-coexisting dopamine with X-ray irradiation upon human glioblastoma cell proliferation"],"prefix":"10.1007","volume":"34","author":[{"given":"Shinya","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"591_CR1","doi-asserted-by":"publisher","first-page":"e78943","DOI":"10.1371\/journal.pone.0078943","volume":"8","author":"T Oike","year":"2013","unstructured":"Oike T, Suzuki Y, Sugawara K, et al. Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results. PLoS ONE. 2013;8:e78943.","journal-title":"PLoS ONE"},{"key":"591_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"591_CR3","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1074\/jbc.M109.054510","volume":"285","author":"EA Cartier","year":"2010","unstructured":"Cartier EA, Parra LA, Baust TB, et al. A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles. J Biol Chem. 2010;285:1957\u201366.","journal-title":"J Biol Chem"},{"key":"591_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.physbeh.2016.04.052","volume":"163","author":"S Amiri","year":"2016","unstructured":"Amiri S, Amini-Khoei H, Mohammadi-Asl A, et al. Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse. Physiol Behav. 2016;163:107\u201314.","journal-title":"Physiol Behav"},{"key":"591_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0166-2236(98)01349-6","volume":"22","author":"A Araque","year":"1999","unstructured":"Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 1999;22:208\u201315.","journal-title":"Trends Neurosci"},{"key":"591_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s13760-016-0730-2","volume":"117","author":"YL Lan","year":"2017","unstructured":"Lan YL, Wang X, Xing JS, Lou JC, Ma XC, Zhang B. The potential roles of dopamine in malignant glioma. Acta Neurol Belg. 2017;117:613\u201321.","journal-title":"Acta Neurol Belg"},{"key":"591_CR7","doi-asserted-by":"publisher","first-page":"88488","DOI":"10.18632\/oncotarget.19691","volume":"8","author":"YL Lan","year":"2017","unstructured":"Lan YL, Wang X, Xing JS, et al. Anti-cancer effects of dopamine in human glioma: involvement of mitochondrial apoptotic and anti-inflammatory pathways. Oncotarget. 2017;8:88488\u2013500.","journal-title":"Oncotarget"},{"key":"591_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s13402-020-00550-4","volume":"43","author":"K Yang","year":"2020","unstructured":"Yang K, Wei M, Yang Z, et al. Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity. Cell Oncol (Dordr). 2020;43:1175\u201390.","journal-title":"Cell Oncol (Dordr)"},{"key":"591_CR9","doi-asserted-by":"publisher","first-page":"109518","DOI":"10.1016\/j.radphyschem.2021.109518","volume":"185","author":"S Kato","year":"2021","unstructured":"Kato S, Kuwata K. Pro-\/anti-oxidative properties of dopamine on membrane lipid peroxidation upon X-ray irradiation. Radiat Phys Chem. 2021;185:109518.","journal-title":"Radiat Phys Chem"},{"key":"591_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF03033188","volume":"3","author":"J Segura-Aguilar","year":"2001","unstructured":"Segura-Aguilar J, Metodiewa D, Baez S. The possible role of one-electron reduction of aminochrome in the neurodegenerative process of the dopaminergic system. Neurotox Res. 2001;3:157\u201365.","journal-title":"Neurotox Res"},{"key":"591_CR11","doi-asserted-by":"publisher","DOI":"10.1515\/dmdi-2020-0109","author":"AN Chernov","year":"2020","unstructured":"Chernov AN, Alaverdian DA, Glotov OS, et al. Related expression of TRKA and P75 receptors and the changing copy number of MYC-oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide. Drug Metab Pers Ther. 2020. https:\/\/doi.org\/10.1515\/dmdi-2020-0109.","journal-title":"Drug Metab Pers Ther."},{"key":"591_CR12","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.7150\/jca.20850","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Liu Q, Liao Q, Zhao Y. Potential roles of peripheral dopamine in tumor immunity. J Cancer. 2017;8:2966\u201373.","journal-title":"J Cancer"},{"key":"591_CR13","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1210\/en.2010-0745","volume":"151","author":"B Rubi","year":"2010","unstructured":"Rubi B, Maechler P. Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let\u2019s seek the balance. Endocrinology. 2010;151:5570\u201381.","journal-title":"Endocrinology"},{"key":"591_CR14","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-08-4289","volume":"69","author":"D Chakroborty","year":"2009","unstructured":"Chakroborty D, Sarkar C, Basu B, Dasgupta PS, Basu S. Catecholamines regulate tumor angiogenesis. Cancer Res. 2009;69:3727\u201330.","journal-title":"Cancer Res"},{"key":"591_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00005072-198105000-00001","volume":"40","author":"DD Bigner","year":"1981","unstructured":"Bigner DD, Bigner SH, Ponten J, et al. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol. 1981;40:201\u201329.","journal-title":"J Neuropathol Exp Neurol"},{"key":"591_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3892\/ijo_00000621","volume":"36","author":"A Yoshino","year":"2010","unstructured":"Yoshino A, Ogino A, Yachi K, et al. Gene expression profiling predicts response to temozolomide in malignant gliomas. Int J Oncol. 2010;36:1367\u201377.","journal-title":"Int J Oncol"},{"key":"591_CR17","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1248\/bpb.19.1518","volume":"19","author":"M Ishiyama","year":"1996","unstructured":"Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull. 1996;19:1518\u201320.","journal-title":"Biol Pharm Bull"},{"key":"591_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-60761-411-1_4","volume":"594","author":"E Eruslanov","year":"2010","unstructured":"Eruslanov E, Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol. 2010;594:57\u201372.","journal-title":"Methods Mol Biol"},{"key":"591_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/ijms21010294","volume":"21","author":"A Chagraoui","year":"2019","unstructured":"Chagraoui A, Boulain M, Juvin L, Anouar Y, Barriere G, Deurwaerdere P. l-DOPA in Parkinson\u2019s disease: looking at the \u201cfalse\u201d neurotransmitters and their meaning. Int J Mol Sci. 2019;21:294.","journal-title":"Int J Mol Sci"},{"key":"591_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21873\/anticanres.13087","volume":"39","author":"A Facoetti","year":"2019","unstructured":"Facoetti A, Cavagnini M, Ciocca M, et al. Effects of l-DOPA pretreatment on the kinetics, migration and carbon ion radiation response of T98G cells. Anticancer Res. 2019;39:119\u201325.","journal-title":"Anticancer Res"},{"key":"591_CR21","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1271\/bbb.61.1646","volume":"61","author":"GC Yen","year":"1997","unstructured":"Yen GC, Hsieh CL. Antioxidant effects of dopamine and related compounds. Biosci Biotechnol Biochem. 1997;61:1646\u20139.","journal-title":"Biosci Biotechnol Biochem"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-021-00591-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-021-00591-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-021-00591-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T07:37:39Z","timestamp":1633419459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-021-00591-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1007\/s13577-021-00591-3","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"7 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}